464
Views
13
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494)

, , , , , & show all
Pages 1814-1822 | Received 12 Mar 2016, Accepted 19 Nov 2016, Published online: 14 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hongxia Lin, Yulian Gao, Yanli Qiu, Haixing Zhu, Shengxiong Zhang, Hanssa Dwarka Summah, Guochao Shi, Tingting Cheng, Zhitao Yang & Yun Feng. (2022) The Prognostic Factors of Bloodstream Infection in Immunosuppressed Elderly Patients: A Retrospective, Single-center, Five-year Cohort Study. Clinical Interventions in Aging 17, pages 1647-1656.
Read now
Michael Roost Clausen, Sinna Pilgaard Ulrichsen, Thomas Stauffer Larsen, Christian B. Poulsen, Selma Tojaga, Per Trøllund Pedersen, Jakob Madsen, Robert Schou Pedersen, Pär Lars Josefsson, Jette Sønderskov Gørløv, Mette Nørgaard & Francesco d’Amore. (2019) Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma – a nationwide population-based cohort study. Leukemia & Lymphoma 60:8, pages 1950-1957.
Read now

Articles from other publishers (11)

Hongxia Lin, Yulian Gao, Yanli Qiu, Wei Du, Haixing Zhu, Junjie Li, Ping Wang, Yumin Xu & Yun Feng. (2022) Impact of age group on bloodstream infection risk evaluation in immunosuppressed patients: a retrospective, single-centre, 5-year cohort study. Aging Clinical and Experimental Research 35:2, pages 357-366.
Crossref
Do Young Kim, Jehyun Nam, Joo-Seop Chung, Byeol Eun Jeon, Ji Hyun Lee, Jae-Cheol Jo, Sang-Woo Kim & Ho-Jin Shin. (2022) Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma. Cancer Research and Treatment 54:4, pages 1256-1267.
Crossref
Anna Ogiso, Tomohiro Mizuno, Kaori Ito, Fumihiro Mizokami, Akihiro Tomita & Shigeki Yamada. (2022) Use of benzodiazepines is the risk factor for infection in patients aged 80 years or older with diffuse large B-cell lymphoma: A single-institution retrospective study. PLOS ONE 17:6, pages e0269362.
Crossref
Megan Fleming, Ying Huang, Emily Dotson, David A. Bond, John Reneau, Narendranath Epperla, Lapo Alinari, Jonathan Brammer, Beth A. Christian, Robert A. Baiocchi, Kami Maddocks & Yazeed Sawalha. (2022) Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas. Blood Advances 6:2, pages 460-472.
Crossref
Samuel Agegnew Wondm, Ephrem Mebratu Dagnew, Sumeya Tadesse Abegaz, Mekdes Kiflu & Bekalu Kebede. (2022) Burden, risk factors, and management of neutropenic fever among solid cancer patients in Ethiopia. SAGE Open Medicine 10, pages 205031212210982.
Crossref
Toby A. Eyre, William WilsonAmy A. KirkwoodJulia WolfCatherine HildyardHannah PlaschkesJohn GriffithPaul FieldsArief GunawanRebecca Oliver, Stephen Booth, Jaimal KothariChristopher P. Fox, Nicolas Martinez-Calle, Andrew McMillan, Mark Bishton, Graham P. CollinsChris S. R. Hatton. (2021) Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP. Blood Advances 5:8, pages 2229-2236.
Crossref
Michael R. Clausen, Sinna P. Ulrichsen, Maja B. Juul, Christian B. Poulsen, Brian Iversen, Per T. Pedersen, Jakob Madsen, Robert S. Pedersen, Pär L. Josefsson, Jette S. Gørløv, Mette Nørgaard & Francesco d'Amore. (2020) Prognostic significance of infectious episodes occurring during first‐line therapy for diffuse large B‐cell lymphoma ‐ A nationwide cohort study. Hematological Oncology 38:3, pages 318-325.
Crossref
Vicki A. Morrison, Laurie Hamilton, Augustina Ogbonnaya, Aditya Raju, Kristin Hennenfent & Aaron Galaznik. (2020) Treatment approaches for older and oldest patients with diffuse large B-cell lymphoma – Use of non-R-CHOP alternative therapies and impact of comorbidities on treatment choices and outcome: A Humedica database retrospective cohort analysis, 2007–2015. Journal of Geriatric Oncology 11:1, pages 41-54.
Crossref
Vicki A. Morrison. 2020. Geriatric Oncology. Geriatric Oncology 583 612 .
Murali Kesavan, Toby A. Eyre & Graham P. Collins. (2019) Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma. Current Hematologic Malignancy Reports 14:4, pages 207-218.
Crossref
Vicki A. Morrison. 2018. Geriatric Oncology. Geriatric Oncology 1 31 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.